Results 1-76 of 76 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12020The impacts of intra-arterial chemotherapy on head and neck microvascular reconstructionKuan C.-H.; Chung M.-J.; RUEY-LONG HONG ; Tseng T.-Y.; Tai H.-C.; Cheng N.-C.; Hsieh J.-H.; Horng S.-Y.; Lai H.-S.Journal of the Formosan Medical Association0
22020Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)Yen C.-J.; Kiyota N.; Hanai N.; Takahashi S.; Yokota T.; Iwae S.; Shimizu Y.; RUEY-LONG HONG ; Goto M.; Kang J.-H.; Li W.S.K.; Ferris R.L.; Gillison M.; Endo T.; Jayaprakash V.; Tahara M.Head and Neck10
32019Primary intradural extramedullary spinal mesenchymal chondrosarcoma: Case report and literature reviewChen C.-W.; Chen I.-H.; Hu M.-H.; Lee J.-C.; Huang H.-Y.; RUEY-LONG HONG ; Yang S.-H.BMC Musculoskeletal Disorders5
42019Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 studyBurtness B.; Harrington K.J.; Greil R.; Souli?res D.; Tahara M.; de Castro G.; Jr, Psyrri A.; Bast? N.; Neupane P.; Bratland ?.; Fuereder T.; Hughes B.G.M.; Mes?a R.; Ngamphaiboon N.; Rordorf T.; Wan Ishak W.Z.; RUEY-LONG HONG ; Gonz?lez Mendoza R.; Roy A.; Zhang Y.; Gumuscu B.; Cheng J.D.; Jin F.; Rischin D.; Lerzo G.; Tatangelo M.; Varela M.; Zarba J.J.; Boyer M.; Gan H.; Gao B.; Hughes B.; Mallesara G.; Taylor A.; Burian M.; Barrios C.H.; de Castro Junior D.O.; Castro G.; Franke F.A.; Girotto G.; Lima I.P.F.; Nicolau U.R.; Pinto G.D.J.; Santos L.; Victorino A.-P.; Chua N.; Couture F.; Gregg R.; Hansen A.; Hilton J.; McCarthy J.; Soulieres D.; Ascui R.; Gonzalez P.; Villanueva L.; Torregroza M.; Zambrano A.; Holeckova P.; Kral Z.; Melichar B.; Prausova J.; Vosmik M.; Andersen M.; Gyldenkerne N.; Jurgens H.; Putnik K.; Reinikainen P.; Gruenwald V.; Laban S.; Aravantinos G.; Boukovinas I.; Georgoulias V.; Kwong D.; Al-Farhat Y.; Csoszi T.; Erfan J.; Horvai G.; Landherr L.; Remenar E.; Ruzsa A.; Szota J.; Billan S.; Gluck I.; Gutfeld O.; Popovtzer A.; Benasso M.; Bui S.; Ferrari V.; Licitra L.; Nole F.; Fujii T.; Fujimoto Y.; Hanai N.; Hara H.; Matsumoto K.; Mitsugi K.; Monden N.; Nakayama M.; Okami K.; Oridate N.; Shiga K.; Shimizu Y.; Sugasawa M.; Takahashi M.; Takahashi S.; Tanaka K.; Ueda T.; Yamaguchi H.; Yamazaki T.; Yasumatsu R.; Yokota T.; Yoshizaki T.; Kudaba I.; Stara Z.; Cheah S.K.; Aguilar Ponce J.; Gonzalez Mendoza R.; Hernandez Hernandez C.; Medina Soto F.; Buter J.; Hoeben A.; Oosting S.; Suijkerbuijk K.; Bratland A.; Brydoey M.; Alvarez R.; Mas L.; Caguioa P.; Querol J.; Regala E.E.; Tamayo M.B.; Villegas E.M.; Kawecki A.; Karpenko A.; Klochikhin A.; Smolin A.; Zarubenkov O.; Goh B.C.; Cohen G.; du Toit J.; Jordaan C.; Landers G.; Ruff P.; Szpak W.; Tabane N.; Brana I.; Iglesias Docampo L.; Lavernia J.; Mesia R.; Abel E.; Muratidu V.; Nielsen N.; Cristina V.; Rothschild S.; Wang H.-M.; Yang M.-H.; Yeh S.-P.; Yen C.-J.; Soparattanapaisarn N.; Sriuranpong V.; Aksoy S.; Cicin I.; Ekenel M.; Harputluoglu H.; Ozyilkan O.; Harrington K.; Agarwala S.; Ali H.; Alter R.; Anderson D.; Bruce J.; Campbell N.; Conde M.; Deeken J.; Edenfield W.; Feldman L.; Gaughan E.; Goueli B.; Halmos B.; Hegde U.; Hunis B.; Jotte R.; Karnad A.; Khan S.; Laudi N.; Laux D.; Martincic D.; McCune S.; McGaughey D.; Misiukiewicz K.; Mulford D.; Nadler E.; Nunnink J.; Ohr J.; O'Malley M.; Patson B.; Paul D.; Popa E.; Powell S.; Redman R.; Rella V.; Rocha Lima C.; Sivapiragasam A.; Su Y.; Sukari A.; Wong S.; Yilmaz E.; Yorio J.The Lancet803
52019Co-encapsulation of chlorin e6 and chemotherapeutic drugs in a pegylated liposome enhance the efficacy of tumor treatment: Pharmacokinetics and therapeutic efficacyPeng P.-C.; RUEY-LONG HONG ; Tsai T.; Chen C.-T.Pharmaceutics5
62019Prognostic factors and treatment outcomes of adult patients with rhabdomyosarcoma after multimodality treatmentLiu Y.-T.; Wang C.-W.; RUEY-LONG HONG ; Kuo S.-H.Anticancer Research6
72018Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 StudyRUEY-LONG HONG ; Hsiao C.F.; Ting L.L.; Ko J.Y.; Wang C.W.; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W.Annals of Oncology70
82018A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell KillingLizotte P.H.; RUEY-LONG HONG ; Luster T.A.; Cavanaugh M.E.; Taus L.J.; Wang S.; Dhaneshwar A.; Mayman N.; Yang A.; Kulkarni M.; Badalucco L.; Fitzpatrick E.; Kao H.-F.; Kuraguchi M.; Bittinger M.; Kirschmeier P.T.; Gray N.S.; Barbie D.A.; Janne P.A.Cancer Immunology Research36
92018Pembrolizumab for the treatment of advanced salivary gland carcinomaCohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG ; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B.American Journal of Clinical Oncology: Cancer Clinical Trials75
102017Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphomaYang C.W.-C.; Wang C.-W.; RUEY-LONG HONG ; Tsai C.-L.; Yao M.; Tang J.-L.; Lin C.-W.; Cheng A.-L.; Kuo S.-H.Journal of Radiation Research6
112017Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinomaLiu C.-W.; Hua K.-T.; Li K.-C.; Kao H.-F.; RUEY-LONG HONG ; Ko J.-Y.; Hsiao M.; Kuo M.-L.; Tan C.-T.Molecular Cancer Therapeutics28
122017Terminally Ill Taiwanese Cancer Patients�� and Family Caregivers�� Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional StudiesLiu T.-W.; Wen F.-H.; Wang C.-H.; RUEY-LONG HONG ; Chow J.-M.; Chen J.-S.; Chiu C.-F.; Tang S.T.Journal of Pain and Symptom Management13
132017Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinomaChen J.L.; Huang Y.-S.; Kuo S.-H.; RUEY-LONG HONG ; Ko J.-Y.; Lou P.-J.; Wang C.-W.Oncotarget13
142017A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG ; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M.Oral Oncology55
152015�\-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancerWu C.-H.; Kuo Y.-H.; RUEY-LONG HONG ; Wu H.-C.Science Translational Medicine20
162015Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatmentPeng P.-C.; RUEY-LONG HONG ; Tsai Y.-J.; Li P.-T.; Tsai T.; Chen C.-T.Lasers in Surgery and Medicine28
172013An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinomaLe Q.-T.; Zhang Q.; Cao H.; Cheng A.-J.; Pinsky B.A.; RUEY-LONG HONG ; Chang J.T.; Wang C.-W.; Tsao K.-C.; Lo Y.M.D.; Lee N.; Ang K.K.; Chan A.T.C.; Chan K.C.A.Clinical Cancer Research89
182013Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trialUrba S.; RUEY-LONG HONG ; Hossain A.M.; Cheng R.; Orlando M.Asia-Pacific Journal of Clinical Oncology1
192013Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implicationHu Z.; Wang J.; Yao T.; RUEY-LONG HONG ; Zhang K.; Gao H.; Wu X.; Li J.; Bai C.; Yen Y.Lung Cancer6
202013Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrenceChen J.L.-Y.; Huang Y.-S.; Kuo S.-H.; Chen Y.-F.; RUEY-LONG HONG ; Ko J.-Y.; Lou P.-J.; Tsai C.-L.; Chen W.-Y.; Wang C.-W.Strahlentherapie und Onkologie23
212012Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineationChen W.-Y.; Kuo S.-H.; Chen Y.-H.; Lu S.-H.; Tsai C.-L.; Chia-Hsien Cheng J.; RUEY-LONG HONG ; Chen Y.-F.; Hsu C.-J.; Lin K.-N.; Ko J.-Y.; Lou P.-J.; Wang C.-P.; Chong F.-C.; Wang C.-W.International Journal of Radiation Oncology Biology Physics1110
222012Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 studyUrba S.; Van Herpen C.M.L.; Sahoo T.P.; Shin D.M.; Licitra L.; Mezei K.; Reuter C.; Hitt R.; Russo F.; Chang S.-C.; Hossain A.M.; Frimodt-Moller B.; Koustenis A.; RUEY-LONG HONG Cancer3429
232012Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancerChua D.T.T.; Yiu H.H.-Y.; Seetalarom K.; Ng A.W.-Y.; Kurnianda J.; Shotelersuk K.; Krishnan G.; RUEY-LONG HONG ; Yang M.-H.; Wang C.-H.; Sze W.-K.; Ng W.-T.Head and Neck30
242012Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapyLin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; RUEY-LONG HONG ; Hsu C.-H.; Chengb A.-L.Oncologist10
252012Clinicopathological features of salivary and non-salivary adenoid cystic carcinomasLin Y.-C.; Chen K.-C.; Lin C.-H.; Kuo K.-T.; Ko J.-Y.; RUEY-LONG HONG International Journal of Oral and Maxillofacial Surgery19
262012A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumorYang S.-H.; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; RUEY-LONG HONG Investigational New Drugs24
272012Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imagingWu L.-A.; Liu H.-M.; Wang C.-W.; Chen Y.-F.; RUEY-LONG HONG ; Ko J.-Y.Radiology19
282010Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinomaShao Y.-Y.; RUEY-LONG HONG Oral Oncology4
292010The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patientsYen R.-F.; Chen C.-Y.; Cheng M.-F.; Wu Y.-W.; Shiau Y.-C.; Wu K.; RUEY-LONG HONG ; Yu C.-J.; Wang K.-L.; Yang R.-S.Nuclear Medicine Communications37
302009Nasion swelling as the presenting symptom of lung adenocarcinomaHuang C.-T.; RUEY-LONG HONG Journal of Thoracic Oncology6
312009Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinomaYen R.-F.; Ting L.-L.; Cheng M.-F.; Wu Y.-W.; Tzen K.-Y.; RUEY-LONG HONG Head and Neck7
322009The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal CarcinomaYen R.-F.; Yen M.-F.; RUEY-LONG HONG ; Tzen K.-Y.; Chien C.-R.; Chen T.H.-H.Academic Radiology21
332008A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclineRUEY-LONG HONG ; Lin C.-H.; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S.Cancer Chemotherapy and Pharmacology6
342008Fatal thrombocytopenia after oxaliplatin-based chemotherapyShao Y.-Y.; RUEY-LONG HONG Anticancer Research19
352006Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysisHsu C.; Shen Y.-C.; Cheng C.-C.; RUEY-LONG HONG ; Chang C.-J.; Cheng A.-L.Cancer Epidemiology Biomarkers and Prevention49
362006Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinomaWang C.-C.; Chang J.-Y.; Liu T.-W.; Lin C.-Y.; Yu Y.-C.; RUEY-LONG HONG Head and Neck45
372005Response of refractory osteosarcoma to thalidomide and celecoxibTsai Y.-C.; Wu C.-T.; RUEY-LONG HONG Lancet Oncology14
382005Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomaChan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG ; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y.Journal of Clinical Oncology207
392005Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinomaYen R.-F.; Chen T.H.-H.; Ting L.-L.; Tzen K.-Y.; Pan M.-H.; RUEY-LONG HONG European Journal of Nuclear Medicine and Molecular Imaging36
402005Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylateLin C.-H.; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; Hsu C.; RUEY-LONG HONG Head and Neck30
412005Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinomaYen R.-F.; RUEY-LONG HONG ; Tzen K.-Y.; Pan M.-H.; Chen T.H.-H.Journal of Nuclear Medicine41
422004Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNARUEY-LONG HONG ; Lin C.-Y.; Ting L.-L.; Ko J.-Y.; Hsu M.-M.Cancer32
432004Recent advances in the treatment of nasopharyngeal carcinomaChang J.T.-C.; Ko J.-Y.; RUEY-LONG HONG Journal of the Formosan Medical Association30
442004Effect of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy on MCF-7 and MCF-7/ADR CellsTsai T.; RUEY-LONG HONG ; Tsai J.-C.; Lou P.-J.; Ling I.-F.; Chen C.-T.Lasers in Surgery and Medicine57
452004Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell LymphomaLi C.-C.; Tien H.-F.; Tang J.-L.; Yao M.; Chen Y.-C.; Su I.-J.; Hsu S.-M.; RUEY-LONG HONG Cancer132
462003A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinomaRUEY-LONG HONG ; Tseng Y.-L.Cancer Chemotherapy and Pharmacology38
472003Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myelomaHuang S.-Y.; Tang J.-L.; Yao M.; Ko B.-S.; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; Tien H.-F.; Shen M.-C.; Chen Y.-C.Annals of Hematology10
482003Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35Chie W.-C.; RUEY-LONG HONG ; Lai C.-C.; Ting L.-L.; Hsu M.-M.Quality of Life Research70
492002Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: Stability, pharmacokinetic and therapeutic evaluationLiu J.-J.; RUEY-LONG HONG ; Cheng W.-F.; Hong K.; Chang F.-H.; Tseng Y.-L.Anti-Cancer Drugs3734
502002Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: A kinetic and efficacy studyTseng Y.-L.; Liu J.-J.; RUEY-LONG HONG Molecular Pharmacology201
512002Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosisWu M.-S.; Lee C.-W.; Sheu J.-C.; Shun C.-T.; Wang H.-P.; RUEY-LONG HONG ; Lee W.-J.; Lin J.-T.Hepato-Gastroenterology20
522002Prognostic value of multidrug resistance 1, glutathione-S-transferase-�k and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapyHsu C.-H.; Chen C.-L.; RUEY-LONG HONG ; Chen K.-L.; Lin J.-F.; Cheng A.-L.Oncology24
532001Anaphylaxis after propocol infusion for Port-A-Cath insertion in a 35-year old manTsai M.-H.; Kuo P.-H.; RUEY-LONG HONG ; Yang P.-C.Journal of the Formosan Medical Association12
542001Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinomaRUEY-LONG HONG ; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; Wang C.-C.; Chung N.-N.; Lui L.T.Journal of Clinical Oncology85
552001Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: The relation between pharmacokinetic property and toxicityRUEY-LONG HONG ; Tseng Y.-L.Cancer
562001Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthmaLee Y.-L.; Ye Y.-L.; Yu C.-I.; Wu Y.-L.; Lai Y.-L.; Ku P.-H.; RUEY-LONG HONG ; Chiang B.-L.Human Gene Therapy35
572001Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 casesHsu M.-M.; RUEY-LONG HONG ; Ting L.-L.; Ko J.-Y.; Sheen T.-S.; Lou P.-J.Archives of Otolaryngology - Head and Neck Surgery41
582000DNA content of nasopharyngeal carcinoma: An independent prognostic indicatorHsu M.-M.; Chiou C.-R.; Ko J.-Y.; Sheen T.-S.; RUEY-LONG HONG ; Ting L.-L.Cancer Detection and Prevention5
592000Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic studyRUEY-LONG HONG ; Tseng Y.-L.; Chang F.-H.Annals of Oncology
601999Curcumin inhibits tyrosine kinase activity of p185(neu) and also depletes p185(neu1)RUEY-LONG HONG ; Spohn W.H.; Hung M.-C.Clinical Cancer Research134
611999Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II studyRUEY-LONG HONG ; Sheen T.S.; Ko J.Y.; Hsu M.M.; Wang C.C.; Ting L.L.British Journal of Cancer
621999Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial?RUEY-LONG HONG ; Huang C.-J.; Tseng Y.-L.; Pang V.F.; Chen S.-T.; Liu J.-J.; Chang F.-H.Clinical Cancer Research202
631999Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma modelTseng Y.-L.; RUEY-LONG HONG ; Tao M.-H.; Chang F.-H.International Journal of Cancer
641998Relation between Histological Intensity of Transforming Growth Factor-�] Isoforms in Human Osteosarcoma and the Rate of Lung MetastasisYang R.-S.; Wu C.-T.; Lin K.-H.; RUEY-LONG HONG ; Liu T.-K.; Lin K.-S.Tohoku Journal of Experimental Medicine1918
651998Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated propertiesZhang L.; Lau Y.-K.; Xi L.; RUEY-LONG HONG ; Kim D.S.H.L.; Chen C.-F.; Hortobagyi G.N.; Chang C.-J.; Hung M.-C.Oncogene100
661997A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancersYeh K.-H.; Cheng A.-L.; Lin M.-T.; RUEY-LONG HONG ; Hsu C.-H.; Lin J.-F.; Chang K.-J.; Lee P.-H.; Chen Y.-C.Anticancer Research27
671997MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancerHsu C.; Yeh K.-H.; RUEY-LONG HONG ; Yang C.-H.; Lin M.-T.; Chen Y.-C.; Cheng A.-L.Journal of the Formosan Medical Association3
681996Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: A retrospective analysis covering a 34-year periodChen H.H.W.; Fong L.; Su I.-J.; Ting L.-L.; RUEY-LONG HONG ; Leung H.W.C.; Lui L.T.Radiotherapy and Oncology3431
691995Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomasRUEY-LONG HONG ; Lee W.-J.; Shun C.-T.; Chu J.-S.; Chen Y.-C.Oncology5247
701995Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell CarcinomaRUEY-LONG HONG ; Pu Y.-S.; Hsieh T.-S.; Chu J.-S.; Lee W.-J.The Journal of Urology5555
711995Clinicopathologic characteristics of helicobacter pyloric seropositive gastric adenocarcinomasLee W.-J.; Lin J.-T.; Lee W.C.; Shun C.-T.; RUEY-LONG HONG ; Cheng A.-L.; Lee P.-H.; Wei T.-C.; Chen K.-M.Journal of Clinical Gastroenterology13
721995Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinomaRUEY-LONG HONG ; Pu Y.-S.; Chu J.-S.; Lee W.-J.; Chen Y.-C.; Wu C.-W.Cancer Letters33
731994Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot studyCheng A.-L.; Su I.-J.; Chen C.-C.; Tien H.-F.; Lay J.-D.; Chen B.-R.; Pu Y.-S.; RUEY-LONG HONG ; Shen M.-C.; Wang C.-H.; Chen Y.-C.Journal of Clinical Oncology45
741993Lymphoblast colony-culture assay in acute lymphoblastic leukemia: A quantitative approachRUEY-LONG HONG ; Shen S.-W.; Lin M.-T.; Tien H.-F.; Yang C.-H.; Chen Y.-C.Leukemia Research1
751992Late survival of non-small cell lung cancer patients with brain metastases: Influence of treatmentChang D.-B.; Yang P.-C.; Luh K.-T.; Kuo S.-H.; RUEY-LONG HONG ; Lee L.-N.Chest42
761992Hodgkin's disease and non?hodgkin's lymphoma containing reed?sternberg?like giant cells in Taiwan: A clinicopathologic analysis of 50 casesRUEY-LONG HONG ; Su I.?J.; Chen Y.?C.; Hsieh H.?C.; Wang C.?H.; Liu C.?H.; Shen M.?C.Cancer8